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Abstract

Results and Discussion

Conclusions

Four peptides were synthesized using solid phase peptide synthesis. The two target peptides
synthesized were based off peptide 18-4 and its negative analog. Each were synthesized once manually,
and once using an automatic peptide synthesizer. Peptide 18-4 has a high affinity for breast cancer cells,
allowing it to be used to detect circulating tumor cells (CTCs) in blood (Kaur et. al, 2015). Manual solid
phase peptide synthesis is performed by anchoring the first amino acid to Wang resin and coupling each
Fmoc protected amino acid individually until the target sequence is achieved. To synthesize the peptides
automatically, the automated Tribute Synthesizer was used. To analyze the success of the peptide
synthesis, mass spectrometry was used to determine if the synthesized peptide has the correct molecular
mass. Reversed Phase-High Performance Liquid Chromatography (RP-HPLC) was used to analyze the
relative amount of the correct peptide in the synthesized sample. Due to greater potential for human error,
the two peptides synthesized manually were missing one or two amino acids. Using the Tribute synthesizer,
peptide 18-4 and its negative analog were successfully synthesized. Automated peptide synthesis was
found to be faster and more successful than manual peptide synthesis.

Introduction
The goal of this research was to successfully synthesize two peptides, peptide 18-4 (NH2 WxEAAYQrFLC - COOH) and its negative analog (NH2 - WxEAAYQrFLC - COOH ). The peptides
synthesized are intended for use in real-time detection of breast cancer cells. Peptide 18-4 has high affinity
for breast cancer cells, and can thus be used with a microcantilever array system to selectively detect
circulating tumor cells in blood. This peptide was discovered by Kaur and her research team at the
University of Alberta (Kaur et. al, 2015).
To synthesize a peptide using solid-phase synthesis, the C terminal amino acid is bound to resin and
then each successive amino acid is coupled to the N-terminus. In solid phase synthesis, the basic
procedure is as follows:
1. Coupling of the first amino acid to resin
2. Deprotection of the first amino acid
3. Activation and coupling of next amino acid
4. Elongation of the peptide (deprotection, activation, coupling)
5. Cleavage of the peptide from the resin
To analyze whether or not the correct amino acids are present in a peptide during or after synthesis,
mass spectrometry is used. The mass ([M+H]+1) of the cleaved peptide is determined using Matrix-Assisted
Laser Desorption/ionization - Time of Flight (MALDI-TOF) mass spectrometry. To determine the relative
amount of the target peptide in a sample or purity of the sample, reversed-phase high performance liquid
chromatography (RP-HPLC) is used. Table 1 outlines the four peptides synthesized.

Peptide 1
• Peptide 1 has two found molecular weights,
which indicates that Peptide 1 consists of two
peptides: one missing glutamate and alanine,
and the other missing alanine from the target
sequence.
• Peptide 1 will not be sufficient at binding to
CTC’s, so manual synthesis of Peptide 18-4 was
unsuccessful.
Peptide 2
• Peptide 2 is missing the amino acid threonine.
Peptide 3
• Peptide 3 was successfully synthesized and
should be able to selectively bind to CTC’s.
• The RP-HPLC of Peptide 3 indicates that a clean,
mostly pure peptide is present.
Peptide 4
• Synthesis of Peptide 4 was at first unsuccessful,
but after manually coupling norleucine, it can be
used as a negative analog of Peptide 4.
• The HPLC of Peptide 4 coupled to norleucine
indicates three peptides are present.
• Because Peptide 4 is to be used as a negative
analog, the presence of two minor peptides will
not interfere with future work.
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Figure 1. Mass Spec of Peptide 1
The mass [M+H]+1 calculated was
1296 Da and the masses found were
1036 Da and 1183 Da.

Figure 2. Mass Spec of Peptide 2
The mass calculated was 1082 Da
and the mass found was 981.46 Da.

Figure 3. Mass Spec of Peptide 3
The mass calculated was 1296 Da
and the mass found was 1296 Da.

Figure 4. Mass Spec of Peptide 4
with norleucine coupled
The mass calculated was 1094 Da
and three masses were found. The
major peak shows a mass of 1095
Da. The minor peaks show masses
of 967 Da, 932 Da and 1024 Da.
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Table 1. Description of Peptides Synthesized
Peptide

Method of Synthesis

In conclusion, manual synthesis was unsuccessful
at synthesizing Peptides 1 and 2. Automated
synthesis was successful at synthesizing Peptides 3
and 4 to be used as Peptide 18-4 and its negative
analog. These peptides are to be used in future
research involving selective binding to CTC’s.

Target Sequence

Calculated
Molecular Weight

Peptide 1

Manual Synthesis by Alicia Cuber

NH2 - WxEAAYQrFL - COOH

1296 Da

Peptide 2

Manual Synthesis

NH2 - EPAAYQRFT - COOH

1082 Da

Peptide 3

Tribute Automatic Synthesizer

NH2 - WxEAAYQrFL - COOH

1296 Da

Peptide 4

Tribute Automatic Synthesizer

NH2 - EPAAYQRFT - COOH

1082 Da
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Materials and Methods
Manual Solid Phase Synthesis: Peptides 1 and 2 were synthesized manually. The 1st amino acid
activated using Oxyma and DIC, was coupled to Wang resin. The amino acid bound to resin was
deprotected from Fmoc using 20% piperidine. The 2nd amino acid activated by dissolving in DMF with
HCTU and NMM, was then added to the resin bound 1st amino acid for coupling. The peptide was
elongated by repeating the deprotection and coupling steps until the peptide was complete. Complete
peptide was cleaved from the resin and purified.
Synthesis Using Tribute Synthesizer: Peptides 3 and 4 were synthesized using the Tribute Synthesizer.
Each amino acid was added to a separate labeled tube with HTCU. Each tube was loaded into the Tribute
Synthesizer and left to synthesize overnight. The peptide was then cleaved and purified as above.
MALDI-TOF and RP-HPLC of Peptide Samples: The calculated molecular weight of the peptide was
found using the website pepcalc.com. After cleavage, the sample was mixed with MALDI matrix and then
spotted onto the MALDI plate. The plate was inserted into the MALDI-TOF and, using the computer
program provided, an appropriate mass range was selected for analysis.
For RP-HPLC of Peptides 3 and 4, 100-500 µL of peptide solution (in DMF and water) was injected.
Each large peak, apart from the very first and very last was collected in a separate tube. Each peak was
analyzed using MALDI-TOF to determine the peak that corresponds to pure peptide.

Figure 5. RP-HPLC of Peptide
The peak that eluted at 51 minutes contained a peptide with a found
mass of 1296 Da, indicating presence of Peptide 3.

Figure 6. RP-HPLC of Peptide 4 with norleucine manually coupled.
Three major peaks eluted, one at 31 minutes, 40 minutes, and 42 minutes. The 31minute peak contained a peptide with a mass of 947 Da and the 42-minute peak
contained a peptide with a mass of 967 Da. The 40-minute elution peak contained a
peptide with the mass of 1095 Da, indicating the presence of Peptide 4 with norleucine
coupled.

Table 2. Summary of Peptides Synthesized
Peptide Name

Target Sequence

Calculated
Molecular Weight

Found
Molecular Weight

Found Sequence

Peptide 1

NH2 - WxEAAYQrFL - COOH

1296 Da

a. 1036 Da
b. 1183 Da

a. NH2 - WxAYQrFL - COOH [M + Na]
b. NH2 - WxEAYQrFL - COOH [M + Na]

Peptide 2

NH2 - EPAAYQRFT - COOH

1082 Da

981.46 Da

NH2 - EPAAYQRF - COOH

Peptide 3

NH2 - WxEAAYQrFLC - COOH

1296 Da

1296 Da

NH2- WxEAAYQrFLC - COOH

Peptide 4
w/ norleucine

NH2 - xEPAAYQRF - COOH

1094 Da

Major: 1095 Da
Minor A: 947
Minor B: 967 Da

Major Pep: NH2 - xEPAAYQRF - COOH
Minor A: NH2 - xEPAAYQR - COOH
Minor B: NH2 - xEPAAYRF - COOH
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